Co
Concert Pharma (Sun)
Lexington MAFounded 200650 employees
Private CapbiotechAcquiredDermatology
Platform: Deuterated SM
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CON-372 | CON-372 | Approved | 3 | MALT1 | NarcolepsyThymoma | ||
| Mavusotorasib | CON-8035 | Phase 1/2 | 1 | B7-H3 | RA |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)